Evidence map›Paper›PMID 34524558›Full record

ArticleJournal of patient-reported outcomes2021

Implementation of a cloud-based electronic patient-reported outcome (ePRO) platform in patients with advanced cancer.

Olga Generalova, Mohana Roy, Evan Hall, Sumit A Shah, Kristen Cunanan, Touran Fardeen, Brianna Velazquez, Gilbert Chu, Bianca Bruzzone, Anna Cabot and 11 more

Open access · goldAbstract read
In one paragraph

Article in Journal of patient-reported outcomes, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 3 pooled it
1.4field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 3 syntheses or guidelines pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Review
  7. Article
  8. Implementation Strategies for Quality Improvement in Palliative Care: A Scoping Review.Health expectations : an international journal of public participation in health care and health policy · 2024
    Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 5 institutions in 1 country.

Olga Generalova *Stanford Cancer Institute, Stanford, USA.
Mohana Roy *Stanford Cancer Institute, Stanford, USA. mohanar@stanford.edu.ORCID http://orcid.org/0000-0002-9997-8935
Evan HallDepartment of Medical Oncology, University of Washington School of Medicine, Seattle, WA, USA.
Sumit A ShahStanford Cancer Institute, Stanford, USA.
Kristen CunananQuantitative Sciences Unit, Stanford University School of Medicine, Stanford, USA.
Touran FardeenStanford Healthcare, Stanford, USA.
Brianna VelazquezStanford Cancer Institute, Stanford, USA.
Gilbert ChuStanford Cancer Institute, Stanford, USA.
Bianca BruzzoneStanford Healthcare, Stanford, USA.
Anna CabotStanford Healthcare, Stanford, USA.
George A FisherStanford Cancer Institute, Stanford, USA.
Sandy SrinivasStanford Cancer Institute, Stanford, USA.
Alice C FanStanford Cancer Institute, Stanford, USA.
Sigurdis HaraldsdottirStanford Cancer Institute, Stanford, USA.
Heather A WakeleeStanford Cancer Institute, Stanford, USA.
Joel W NealStanford Cancer Institute, Stanford, USA.
Sukhmani K PaddaStanford Cancer Institute, Stanford, USA.
Tyler JohnsonStanford Cancer Institute, Stanford, USA.
Gregory M HeestandStanford Cancer Institute, Stanford, USA.
Robert W HsiehStanford Cancer Institute, Stanford, USA.
Kavitha RamchandranStanford Cancer Institute, Stanford, USA.
Stanford Cancer InstituteStanford Health Care · USCardiovascular Institute of the South · USStanford University · USUniversity of Washington Medical Center · US

Funding

Varian Medical Systems (US) VAFYZ
6 · The paper itself

Abstract

backgroundPatient reported outcomes (PROs) have been associated with improved symptom management and quality of life in patients with cancer. However, the implementation of PROs in an academic clinical practice has not been thoroughly described. Here we report on the execution, feasibility and healthcare utilization outcomes of an electronic PRO (ePRO) application for cancer patients at an academic medical center.

methodsWe conducted a randomized trial comparing an experimental ePRO arm to standard of care in patients with advanced cancer in the thoracic, gastrointestinal, and genitourinary oncology groups at Stanford Cancer Center from March 2018 to November 2019. We describe the pre-implementation, implementation, and post-implementation phases of the ePRO arm, technological barriers, electronic health record (EHR) integration, clinician burden, and patient data privacy and security. Feasibility was pre-specified to be at least 70% completion of all questionnaires. Acceptability was based on patient and clinician feedback. Ambulatory healthcare utilization was assessed by reviewing numbers of phone messages, electronic portal messages, and referrals for supportive care.

resultsOf 617 ePRO questionnaires sent to 72 patients, 445 (72%) were completed. Most clinicians (87.5%) and patients (93%) felt neutral or positive about the ePRO tool's ease of use. Exposure to ePRO did not cause a measurable change in ambulatory healthcare utilization, with a median of less than two phone messages and supportive care referrals, and 5-6 portal messages.

conclusionsWeb-based ePRO tools for patients with advanced cancer are feasible and acceptable without increasing clinical burden. Key lessons include the importance of pilot testing, engagement of stakeholders at all levels, and the need for customization by disease group. Future directions for this work include completion of EHR integration, expansion to other centers, and development of integrated workflows for routine clinical practice.

Indexed as

Care-deliveryHealthcare utilizationPatient reported outcomesQuality of life

Identifiers

PMID34524558
PMCPMC8443731
OpenAlexW3199546720

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.